Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sorafenib in Advanced Soft Tissue Sarcomas
NCT00217620Phase 2Completed
- Sponsor
- National Cancer Institute
- Start
- Mar 2006
- Primary completion
- Apr 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sorafenib in soft tissue sarcoma (STS), sponsored by National Cancer Institute. Started Mar 2006; status: completed.
02
Drugs
sorafenib
03
Conditions
soft tissue sarcoma (STS)
Beyond the preview
Go deeper on NCT00217620.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00217620.